Page 78 - RESUME NOTE REMINDER

euthyroid multinodular goiter. Further studies are required to investigate the potential

association between thyroid autoimmunity and carcinoma, as a helpful indication for
surgical referral.

17. The effect of peritoneal dialysis modality selection and new dialysis solutions on

patients survival.

Marios Theodoridis2, Stylianos Panagoutsos2, Konstantia Kantartzi,Despoina

Chatzidimitriou2, Eleni Triantafyllidou2, Michael Karanikas,Ploumis Passadakis

Ανακοινώθηκε στο 55th ERA-EDTA CONGRESS Copenhagen Denmark May 24th -
27th 2018

Δημοσιεύτηκε στο Nephrology Dialysis Transplantation , Volume 33, Issue suppl_1,

May 2018, Pages i521–i522, https://doi.org/10.1093/ndt/gfy104.SP514

Αbstract

Introduction and aims: Peritoneal dialysis (PD) is an established treatment forESRD

patients; it has a variety of advantages, including autonomy and flexibility, aswell as
economic benefits in many countries compared to hemodialysis (HD).However, the

long-term survival rate of PD remains poor and its correlated with altera-tions in
peritoneal membrane during the time on PD which may lead to ultrafiltrationfailure

or/and inadequate clearance of small solutes It has also been a crucial point
thepossibility of increased cardiovascular risk when prescribing automated peritoneal

dial-ysis due to impaired sodium removal which may lead to fluid overload. The aim
of thestudy was to retrospectively evaluate the possible effect of peritoneal dialysis

modalityand new dialysis solutions on patients’ survival.

Methods: This is a single center retrospective study of 380 PD patients
(m¼225,f¼155) conducted for the time period 1992 to 2017(25 years). From these

patients 217where on CAPD (continues ambulatory peritoneal dialysis) and 163
where on CCPD(continues cycler peritoneal dialysis). For the CAPD group the mean

age was 63614years and for the CCPD group was 64615 years (p¼0,539). The
incidence of diabetesbetween the two groups had no statistically significant

difference (p¼0,065), CAPD:52/217 (24%) and CCPD: 53/163 (32%). Additionally,
during this period 51 patients(CAPD 9 pts, CCPD 42 pts) used biocompatible

peritoneal dialysis solutions low inGDPs, normal pH and bicarbonate as a buffer
system. Subsequently the survival analysis of the PD patients was calculated by

78